Assessing the cost-effectiveness of immunomodulatory therapies for relapsing-remitting multiple sclerosis based on long-term data
Citation
Bell, C., Graham, J., Earnshaw, S., Oleen-Burkey, M., Castelli-Haley, J., & Johnson, KP. (2006). Assessing the cost-effectiveness of immunomodulatory therapies for relapsing-remitting multiple sclerosis based on long-term data. Value in Health, 9(3), A81-A82.